Judge extends deadline in lawsuit seeking to pull abortion pill mifepristone from U.S. until Feb. 24
Publishing timestamp: 2023-02-10 12:48:35
Summary
A federal judge in Texas has extended the deadline in a lawsuit seeking to overturn the Food and Drug Administration's approval of the abortion pill mifepristone until Feb. 24. The Alliance for Hippocratic Medicine, a coalition of physicians who oppose abortion, sued the FDA in November. An analysis by the abortion rights group NARAL Pro-Choice America said 40 million women would lose access to the abortion pill if the Alliance succeeds. The FDA has argued that the lawsuit is "extraordinary and unprecedented" and that mifepristone was approved based on extensive scientific evidence. Separate lawsuits are also seeking to overturn state restrictions on mifepristone. Republican attorneys general in 20 states have also warned CVS and Walgreens against mailing the abortion pill in their states.
Sentiment: NEUTRAL
Keywords: breaking news: business, cvs health corp, health care industry, pandemics, business, biotech and pharmaceuticals, business news, politics, walgreens boots alliance inc, epidemics, u.s. economy, biotechnology,